Alignment Healthcare (NASDAQ:ALHC) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Alignment Healthcare (NASDAQ:ALHC) had its price target boosted by stock analysts at Stifel Nicolaus from $18.00 to $23.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would suggest a potential upside of 15.50% from the company’s previous close.

ALHC has been the subject of several other research reports. Barclays upped their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research report on Friday, February 28th. Stephens restated an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a report on Monday, February 24th. Bank of America lifted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Finally, JPMorgan Chase & Co. lifted their target price on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $15.39.

Alignment Healthcare Price Performance

ALHC stock traded up $2.09 on Tuesday, hitting $19.91. 2,446,740 shares of the company’s stock traded hands, compared to its average volume of 1,563,400. The stock has a fifty day moving average of $15.69 and a 200-day moving average of $13.29. The stock has a market cap of $3.82 billion, a price-to-earnings ratio of -25.86 and a beta of 1.32. Alignment Healthcare has a 1-year low of $4.62 and a 1-year high of $21.05. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Insiders Place Their Bets

In related news, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $13.61, for a total value of $408,300.00. Following the completion of the transaction, the president now directly owns 1,606,097 shares of the company’s stock, valued at $21,858,980.17. The trade was a 1.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Sebastian Burzacchi sold 6,694 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $16.40, for a total transaction of $109,781.60. Following the sale, the chief operating officer now directly owns 250,378 shares in the company, valued at approximately $4,106,199.20. This represents a 2.60 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,981,855 shares of company stock worth $30,590,612 over the last 90 days. Corporate insiders own 6.60% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. R Squared Ltd acquired a new position in shares of Alignment Healthcare during the fourth quarter valued at $55,000. RiverPark Advisors LLC acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth approximately $106,000. Tower Research Capital LLC TRC raised its stake in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after buying an additional 6,286 shares during the last quarter. Ballentine Partners LLC acquired a new position in Alignment Healthcare in the fourth quarter valued at approximately $121,000. Finally, Aigen Investment Management LP acquired a new stake in Alignment Healthcare during the 4th quarter worth $129,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.